Theonie Anastassiadis

Founder at Flagship Labs 89, Inc.

Health Technology

Finance

Consumer Services

Profile

Ms. Theonie Anastassiadis is a Chief Innovation Officer at Alltrna, a President at Prologue Medicines, Inc. and a Principal at Flagship Pioneering.
She received her undergraduate degree from Haverford College.

Theonie Anastassiadis active positions

Companies	Position	Start
Flagship Pioneering Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.	Private Equity Analyst	-
Alltrna Alltrna BiotechnologyHealth Technology Alltrna is a biotech company that uses AI/ML tools to learn the language of tRNA and develop programmable molecules with therapeutic potential. Alltrna was founded in 2018 by Flagship Pioneering and is based in Cambridge, MA. The company aims to correct diseases by advancing a single tRNA medicine to treat a wide range of diseases with the same underlying genetic mutation. The company's CEOs are Michelle C. Werner and Lovisa Afzelius.	Founder	-
Flagship Labs 89, Inc.	Founder	-

All active positions of Theonie Anastassiadis

Training of Theonie Anastassiadis

Haverford College

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Theonie Anastassiadis's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Flagship Pioneering Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.	Finance
Alltrna Alltrna BiotechnologyHealth Technology Alltrna is a biotech company that uses AI/ML tools to learn the language of tRNA and develop programmable molecules with therapeutic potential. Alltrna was founded in 2018 by Flagship Pioneering and is based in Cambridge, MA. The company aims to correct diseases by advancing a single tRNA medicine to treat a wide range of diseases with the same underlying genetic mutation. The company's CEOs are Michelle C. Werner and Lovisa Afzelius.	Health Technology
Flagship Labs 89, Inc.	Health Technology

See company connections